info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_RENAL_PELVIS_EXALLC for full statistics.

Malignant neoplasm of renal pelvis

C3_RENAL_PELVIS

renal pelvis carcinoma: A carcinoma arising in the renal pelvis. The majority of renal pelvis carcinomas are transitional cell and less frequently squamous cell carcinomas.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C65
  • Cause of death: ICD-9 1891
  • Cause of death: ICD-8 1891
  • Cancer registry: Topography ICD-O-3 C65
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

186

4. Check minimum number of events

None

186

5. Include endpoints

None

186

6. Filter based on genotype QC (FinnGen only)

186

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 186 51 135
Unadjusted period prevalence (%) 0.05 0.02 0.06
Median age at first event (years) 71.99 70.91 72.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
173
Matched controls
1728
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
13394.5
207.5
156
*
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
189.0
145
*
UKC02
NOMESCO Finland
Cystoscopy
27.2
75.6
143
257
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
61.1
55
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
136.5
54.7
56
6
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
52.9
48
*
R31
ICD-10 Finland
Unspecified haematuria
14.0
49.6
102
161
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
21.5
33.4
50
32
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
22.2
27.4
40
23
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
75.9
23.6
26
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
17.8
23.5
37
26
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
32.6
23.2
30
11
C66
ICD-10 Finland
Malignant neoplasm of ureter
224.6
20.0
20
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
13.4
19.8
35
32
UKB02
NOMESCO Finland
Retrograde ureteroscopy
30.3
19.8
26
10
130
Kela drug reimbursment
Malignant tumour
6.1
15.4
45
94
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
18.7
15.3
23
14
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
12.6
15.1
27
25
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.0
13.5
31
46
B01AB10
ATC
tinzaparin; parenteral
6.3
13.1
36
69
7126
FHL
Nephroureterectomy
+∞
12.7
12
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.0
12.4
31
52
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
16.2
12.1
19
13
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
18.1
12.0
18
11
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
20.8
11.8
17
9
8000/3-C65.9
ICD-O-3
Neoplasm, malignant of renal pelvis
+∞
11.6
11
*
8130/3-C65.9
ICD-O-3
Papillary urothelial carcinoma of renal pelvis
+∞
10.5
10
*
1891C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,MUU/TARK MÄÄR SYÖPÄ]
+∞
10.5
10
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
9.0
10.2
21
26
Z51.5
ICD-10 Finland
Palliative care
5.5
10.1
30
63
A04AA02
ATC
granisetron; systemic, transdermal
6.8
10.0
25
42
B02AA02
ATC
tranexamic acid; systemic
4.5
9.8
36
95
JN4AD
NOMESCO Finland
Body CT examination
5.0
9.8
32
75
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
9.2
42
136
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
8.8
52
205
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
8.8
40
129
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.5
7.7
27
68
ZX136
NOMESCO Finland
Intravesicalis
19.4
7.7
11
6
KAC10
NOMESCO Finland
Total nephrectomy with capsule
14.2
7.5
12
9
U06
ICPC
Haematuria
6.8
7.5
18
29
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
7.3
7
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
16.7
7.3
11
7
KH1AD
NOMESCO Finland
CT of urinary organs
6.6
7.0
17
28
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
23.6
6.7
9
*
B01AB05
ATC
enoxaparin; parenteral
2.5
6.7
66
347
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
12.9
6.7
11
9
J01EA01
ATC
trimethoprim; systemic
2.6
6.6
54
256
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
6.6
28
85
N02AA05
ATC
oxycodone; systemic
2.8
6.5
46
199
KC1GB
NOMESCO Finland
Cystography with X-ray
11.6
6.4
11
10
KA3GB
NOMESCO Finland
Retrograde pyelography
+∞
6.3
6
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
13.2
6.2
10
8
JN4BD
NOMESCO Finland
Extensive body CT
3.1
6.0
34
128

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
80
76
17.72
79.17
6.4
3.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
105
552
3.07
12.78
6.6
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
94
468
3.04
12.56
5.1
3.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
84
3.75
8.32
9.1
8.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
66
330
2.55
8.03
4.7
2.9
e6/l
3.3
4.0
0.52
60
288
(3023368) Bacteria identified in Blood by Culture
85
488
2.37
7.55
4.2
4.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
101
645
2.24
6.75
5.8
4.4
g/l
32.1
34.4
3.23
91
606
(4035726)
32
120
3.01
6.67
1.3
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
60
310
2.38
6.63
4.7
3.2
mosm/kgh2o
554.0
583.2
0.61
52
266
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
98
626
2.20
6.46
6.3
4.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
80
475
2.20
6.30
6.8
3.7
e6/l
125.8
224.9
0.29
69
371
(36304419) Bacteria [Presence] in Urine
68
391
2.17
5.69
7.1
3.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
43
204
2.44
5.65
7.3
6.1
kpa
5.2
5.0
0.49
38
194
(3027801) Oxygen [Partial pressure] in Arterial blood
43
205
2.43
5.59
7.3
6.1
kpa
13.1
11.6
1.06
38
196
(3030467) Casts [#/volume] in Urine by Automated count
70
418
2.08
5.24
7.1
3.5
e6/l
0.2
0.5
1.85
61
314
(3018095) Leukocytes [#/volume] in Urine
83
528
2.03
5.23
7.3
4.2
e6/l
104.0
123.3
0.17
72
392
(3003396) Base excess in Arterial blood by calculation
42
204
2.37
5.22
7.4
6.2
mmol/l
-0.6
1.1
1.22
27
158
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
98
668
1.99
5.02
8.7
5.9
mmol/l
1.2
1.2
0.50
90
594
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
103
724
1.95
4.73
9.5
6.6
mmol/l
1.2
1.2
0.24
83
604
(40761535) Cells panel - Urine sediment
29
124
2.59
4.70
5.4
3.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
115
848
1.93
4.48
6.4
4.8
mmol/l
6.8
6.9
0.30
107
806
(3032080) INR in Blood by Coagulation assay
94
649
1.91
4.48
10.4
9.9
inr
1.5
1.4
0.41
25
166
(3037467) Urinalysis macro (dipstick) panel - Urine
120
914
1.88
4.06
8.0
4.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
59
359
1.94
4.03
3.1
2.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
71
462
1.87
3.95
3.3
2.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
72
472
1.86
3.91
4.1
3.2
mmol/l
2.3
2.3
0.93
61
404
(3013650) Neutrophils [#/volume] in Blood by Automated count
99
736
1.74
3.39
11.4
9.2
e9/l
4.9
4.4
0.62
91
637
(3017704) Immunofixation for Urine
6
8
7.70
3.07
1.2
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
64
434
1.72
2.96
5.4
4.2
ph
7.4
7.4
0.37
15
86
(3019060) Gas panel - Arterial blood
25
124
2.17
2.93
4.8
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
244
1.87
2.92
6.7
3.1
e6/l
2.4
1.0
0.57
33
146
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
53
2.78
2.86
5.0
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
71
503
1.67
2.77
2.8
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
137
2.04
2.62
10.8
8.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
9
25
3.73
2.61
2.0
1.2
e6/l
408.7
1726.1
—
9
18
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
8
21
3.93
2.49
1.6
1.2
u/l
198.5
206.0
—
8
21
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
23
118
2.08
2.48
4.7
3.9
ng/l
90.8
96.7
0.14
18
103
(3018677) aPTT in Platelet poor plasma by Coagulation assay
40
249
1.77
2.46
1.8
1.7
s
29.8
29.5
0.09
40
240
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
12
5.13
2.42
1.0
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
12
5.13
2.42
1.0
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
40
2.86
2.42
2.3
2.3
mg/l
1.8
1.8
0.00
11
33
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
243
1.77
2.39
7.0
3.4
e6/l
1.0
1.9
0.70
30
148
(3035637) Corticotropin [Mass/volume] in Plasma
6
13
4.73
2.29
1.5
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
27
153
1.89
2.23
5.4
4.2
mmol/l
2.1
1.9
0.05
15
119
(3036481) Cortisol [Moles/volume] in Serum or Plasma
22
118
1.98
2.12
1.8
1.7
nmol/l
399.0
395.8
0.02
22
103
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
25
3.30
2.12
1.3
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
34
211
1.75
2.11
2.6
2.9
%
1.5
1.8
1.00
29
189
(3012441) Differential panel - Pleural fluid
7
22
3.26
1.90
1.4
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
12
4.25
1.83
3.0
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
35
2.65
1.82
2.4
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
26
156
1.77
1.81
1.5
1.3
—
—
—
0
0
(3012544) pH of Venous blood
26
156
1.77
1.81
5.8
4.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
118
1.88
1.79
1.6
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
81
641
1.47
1.78
6.3
4.2
estimate
0.0
0.0
0.00
22
104
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
169
1.70
1.63
2.2
4.4
ug/l
87.5
49.6
0.17
21
142
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
14
3.64
1.62
4.8
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
79
632
1.43
1.60
6.9
5.5
estimate
0.0
0.0
0.00
21
111
(3022313) Gas panel - Capillary blood
16
86
1.94
1.56
6.8
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
41
290
1.53
1.53
7.4
4.6
kg/l
1.0
1.0
—
9
43
(3045788) Cell count panel - Pleural fluid
6
21
2.92
1.52
1.8
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
58
442
1.45
1.51
2.8
3.2
mg/l
111.3
197.5
0.27
41
303
(3009508) Creatinine [Moles/volume] in Urine
58
442
1.45
1.51
2.8
3.2
mmol/l
6.5
7.4
1.08
45
359
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
73
1.99
1.48
2.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
301
1.51
1.47
4.8
4.0
ng/l
28.5
235.1
1.96
34
260
(3044927) Protein electrophoresis panel - Urine
5
16
3.18
1.44
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
16
3.18
1.44
3.4
2.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.38
1.2
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.38
1.3
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
68
1.98
1.37
2.5
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
0
37
0.00
1.36
0.0
1.5
—
246.9
—
0
24
(3019198) Lymphocytes [#/volume] in Blood
78
638
1.38
1.34
5.9
5.8
e9/l
1.6
1.8
0.67
68
557
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
122
1.72
1.34
6.2
3.0
kpa
5.4
5.0
0.78
15
111
(3052851) Hemolysis interference index of Serum or Plasma
10
48
2.14
1.30
5.7
4.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
48
363
1.43
1.29
7.3
4.6
estimate
0.0
0.0
0.00
16
105
(1616796) Gas panel - Central venous blood
8
35
2.34
1.28
3.6
3.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
18
108
1.74
1.27
6.7
3.2
mmol/l
1.7
1.8
0.00
13
80
(40768806) Pleura Pathology biopsy report
6
25
2.45
1.25
1.3
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
94
1.77
1.22
3.1
3.5
ml/min/173m2
33.6
53.0
—
8
41
(4094501)
0
33
0.00
1.17
0.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
44
334
1.42
1.15
7.6
6.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
9
163
0.53
1.15
1.0
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
76
632
1.34
1.14
6.2
4.2
estimate
0.0
0.0
0.00
22
113
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
61
491
1.36
1.13
7.0
4.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
39
291
1.43
1.12
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
129
1.62
1.11
2.2
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
21
2.42
1.09
4.8
5.4
mg/l
13.9
11.9
—
5
21
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
21
2.42
1.09
1.4
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
52
1.98
1.08
1.0
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
75
628
1.33
1.06
5.9
5.7
e9/l
0.7
0.6
1.21
66
532
(3020682) Albumin/Creatinine [Ratio] in Urine
58
469
1.34
1.04
3.6
3.9
mg/mmol
14.5
10.0
0.62
38
311
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
22
2.31
1.04
4.2
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
22
2.31
1.04
3.6
3.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
22
2.31
1.04
5.4
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
75
630
1.32
1.04
5.9
5.8
e9/l
0.0
0.0
0.19
66
539
(3037756) Immunofixation for Serum or Plasma
9
48
1.92
1.02
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
107
1189
0.76
1.00
7.8
7.0
mmol/mol
41.3
41.8
0.24
94
1091
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
23
2.21
0.98
4.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
24
167
1.50
0.98
1.6
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
36
1.98
0.98
1.1
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
17
109
1.62
0.97
2.4
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
76
645
1.30
0.96
6.1
5.9
e9/l
0.2
0.2
0.02
65
561
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
32
0.00
0.96
0.0
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.93
0.95
1.1
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
27
2.26
0.94
1.5
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
28
2.18
0.92
4.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
22
155
1.48
0.86
6.2
4.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
26
347
0.71
0.85
3.6
3.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
57
1.80
0.85
2.4
2.1
—
1.6
—
0
5
(3026493) Urate [Moles/volume] in Serum or Plasma
46
371
1.32
0.83
3.3
3.0
umol/l
10723.3
7689.6
0.11
39
305
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
136
1258
1.30
0.83
27.6
18.5
mg/l
44.3
27.3
4.99
130
1061
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
47
1.73
0.82
1.1
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
113
1232
0.79
0.81
5.2
5.2
mmol/l
6.0
6.2
1.07
97
1092
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
54
449
1.29
0.78
2.1
2.2
u/l
121.8
260.5
2.20
49
418
(3022621) pH of Urine by Test strip
15
99
1.56
0.78
7.6
2.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
24
2.11
0.75
1.2
2.0
e9/l
4.1
5.3
—
5
24
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
1.6
2.3
—
—
—
0
0
(3020891) Body temperature
11
68
1.66
0.73
6.2
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
82
722
1.24
0.73
3.2
3.2
u/l
63.5
57.7
0.16
77
663
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
25
2.03
0.73
1.2
2.6
%
64.6
61.8
—
5
25
(3022217) INR in Platelet poor plasma by Coagulation assay
33
259
1.33
0.72
29.8
29.2
inr
1.5
1.4
—
6
34
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
106
1156
0.81
0.71
3.7
4.3
mmol/l
1.2
1.3
0.02
93
1022
(3041096) Erythrocytes [Presence] in Urine by Automated
42
342
1.29
0.71
5.5
4.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
16
110
1.50
0.71
6.0
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
29
224
1.35
0.70
2.2
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
53
447
1.26
0.68
6.9
5.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
29
227
1.33
0.65
3.3
2.4
%
18.1
22.2
1.12
21
202
(3044889) 12 lead EKG panel
100
908
1.22
0.65
4.7
4.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14
198
0.68
0.64
1.3
1.4
g/l
2.5
3.0
—
9
116
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
42
347
1.27
0.64
1.5
1.8
pmol/l
409.0
433.5
0.26
30
288
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
192
1.35
0.63
2.0
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
357
1.27
0.63
2.0
1.8
nmol/l
1087.1
1210.7
0.29
33
269
(3013707) Erythrocyte sedimentation rate by Westergren method
103
942
1.21
0.60
5.2
4.3
mm/h
22.7
15.5
2.13
89
853
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
158
1.37
0.60
5.1
3.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
81
725
1.21
0.59
4.3
5.5
ug/l
2.3
3.3
0.86
62
634
(3021788) Differential panel - Synovial fluid
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
111
1192
0.83
0.57
4.2
4.8
mmol/l
1.3
1.4
0.80
100
1060
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
112
1201
0.83
0.57
4.3
4.8
mmol/l
4.2
4.3
0.77
99
1079
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
269
1.28
0.56
2.0
1.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
37
1.64
0.56
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
111
1029
1.20
0.54
31.7
20.2
%
35.9
38.4
1.38
64
635
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
191
1.29
0.49
1.9
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
48
550
0.83
0.49
2.5
2.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
14
102
1.40
0.49
2.6
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
117
1238
0.85
0.45
4.6
5.5
mmol/l
2.3
2.5
1.98
100
1101
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
46
401
1.20
0.44
2.2
2.1
mg/l
2.6
3.2
1.07
40
347
(40768443) Skin Pathology biopsy report
8
57
1.42
0.42
1.0
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
15
0.00
0.41
0.0
2.3
—
809.4
—
0
7
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
169
1.27
0.41
14.0
9.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
28
236
1.22
0.37
4.2
5.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
188
0.78
0.35
3.8
4.9
%
30.3
32.0
—
6
121
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
276
1.19
0.35
1.5
1.6
mg/l
1.6
1.6
0.06
27
221
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
44
1.38
0.35
1.3
1.5
—
—
—
0
0
(3000492) Spirometry study
6
86
0.69
0.34
1.3
1.5
—
—
—
0
0
(3013512) EKG study
50
450
1.15
0.33
4.4
4.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
113
1180
0.89
0.28
27.6
17.8
ml/min/173m2
54.4
71.3
14.04
101
972
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
15
122
1.25
0.28
3.5
2.8
u/l
38.4
32.8
0.29
15
95
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
64
1.26
0.28
2.8
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
73
0.68
0.26
1.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
170
0.81
0.26
1.3
1.3
iu/ml
14.7
37.3
—
7
64
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
68
636
1.11
0.24
3.9
4.5
ng/l
31.9
45.0
1.12
57
499
(3005322) IgE [Units/volume] in Serum or Plasma
5
40
1.26
0.22
1.4
1.3
u/ml
80.3
102.7
—
5
34
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
41
1.23
0.22
1.0
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
41
1.23
0.22
1.2
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
0
12
0.00
0.21
0.0
2.0
—
499.2
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
109
1130
0.91
0.21
5.1
4.4
mu/l
1.9
2.1
0.87
99
985
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(4268621)
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
135
1313
1.10
0.20
37.6
22.3
umol/l
118.1
88.2
9.50
135
1313
(1761482) Bacteria [#/volume] in Urine by Culture
6
50
1.21
0.20
4.5
5.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
118
1.20
0.19
2.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
3.0
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
60
1.17
0.18
1.1
1.3
—
31.8
—
0
5
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
409
0.91
0.16
3.3
3.2
ug/l
0.9
0.9
0.04
21
281
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
99
0.80
0.14
1.1
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
130
1273
1.07
0.13
29.6
17.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
54
514
1.07
0.13
3.6
2.7
ug/l
248.1
155.3
1.16
48
460
(3011397) Hemoglobin [Presence] in Urine by Test strip
32
298
1.09
0.12
7.3
4.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
134
1315
1.07
0.12
13.7
11.4
u/l
21.6
24.3
1.53
129
1258
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
91
889
1.05
0.08
4.0
3.5
pmol/l
15.3
15.1
0.32
78
773
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
62
0.80
0.08
1.0
1.2
g/l
36.6
36.4
—
5
50
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
108
1.12
0.07
1.2
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
80
0.87
0.07
4.3
4.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
102
0.88
0.06
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
16
149
1.08
0.05
1.8
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
17
159
1.08
0.05
3.5
2.5
umol/l
6.9
11.2
0.75
17
134
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
51
524
0.96
0.05
1.9
2.2
nmol/l
73.8
77.3
0.40
41
452
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
570
1.03
0.02
4.5
4.9
%
22.3
21.8
0.10
29
287
(4010399)
10
93
1.08
0.02
1.6
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
11
103
1.07
0.02
5.8
2.3
g/l
11.7
10.1
0.43
11
90
(3026361) Erythrocytes [#/volume] in Blood
136
1354
1.02
0.00
41.5
26.9
e12/l
4.1
4.4
6.94
131
1297
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
101
0.99
0.00
2.1
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
10
101
0.99
0.00
1.8
2.1
nmol/l
8.6
12.1
—
10
91
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
62
621
1.00
0.00
2.3
2.1
pmol/l
91.3
92.8
0.13
34
329
(3021589) Normoblasts [#/volume] in Blood
55
548
1.01
0.00
13.5
10.8
e9/l
0.0
0.0
0.51
46
442
(3022145) Colonoscopy Study observation
16
155
1.04
0.00
1.4
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.4
—
229.8
—
0
8
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
73
0.96
0.00
1.1
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
64.5
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
69
0.87
0.00
1.0
1.2
g/l
11.2
10.3
—
6
58
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
7.3
—
44.4
—
0
7
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
22.4
—
0
6
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
8.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
2730.0
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
65
0.92
0.00
1.3
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
9.6
—
0
6
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
77
0.91
0.00
1.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
9.9
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_RENAL_PELVIS – Malignant neoplasm of renal pelvis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).